Related Experiment Video

Updated: Jul 14, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by

Ryoko Mitsutake1, Shin-ichiro Miura, Keisuke Okamura

  • 1Department of Cardiology, Fukuoka University School of Medicine.

Internal Medicine (Tokyo, Japan)
|June 19, 2007
PubMed

Insights

This case study shows that multi-detector row computed tomography (MDCT) can assess coronary plaque changes. Intensive statin therapy, like atorvastatin, effectively reduced low-density lipoprotein cholesterol and improved plaque density.

Area of Science:

  • Cardiovascular Medicine
  • Radiology
  • Pharmacology

Background:

  • A 35-year-old male presented with angina pectoris, indicating potential coronary artery disease.
  • Severe stenosis with soft plaque in the left anterior descending (LAD) coronary artery was identified via multi-detector row computed tomography (MDCT).

Observation:

  • Percutaneous coronary stent implantation was performed, yet residual soft plaque persisted in the LAD lesion.
  • Follow-up MDCT at 6 months revealed increased coronary plaque density after atorvastatin treatment.

Findings:

  • Atorvastatin therapy led to a significant reduction in low-density lipoprotein cholesterol levels, from 141 to 63 mg/dl.
  • The observed increase in coronary plaque density suggests a potential stabilization or regression of atherosclerotic plaque.

Implications:

  • MDCT imaging is a valuable tool for evaluating the composition and shape of coronary plaques.
  • Assessing plaque characteristics with MDCT can help judge the efficacy of intensive lipid-lowering therapies, such as statins.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...